Patients with hematological malignancies are at risk for a number of infections that are
potentially preventable by vaccinations such as pneumococcal infections and influenza …

Post-transplantation revaccination uptake of childhood vaccines in adult hematopoietic stem
cell transplantation (HSCT) survivors is suboptimal, increasing the risk of infectious morbidity …

Background Vaccination is the primary method for preventing influenza respiratory virus
infection (RVI). Although the influenza vaccine is able to achieve serological responses in …

Background Hematopoietic stem cell transplant (HCT) recipients are more susceptible to
infections from vaccine‐preventable diseases than the general population. Despite the …

Background Infections, including common communicable infections such as influenza,
frequently cause disease after organ transplantation, although the quantitative extent of …

Background Revaccination after hematopoietic stem cell transplantation (HSCT) is
necessary to compensate for the loss of immunological memory. The aims of this study were …

Revaccination after hematopoietic cell transplantation (HCT) is critical to prevent morbidity
and mortality from vaccine-preventable illnesses. The global aim of our quality improvement …

Comprehensive survivorship care after hematopoietic cell transplantation (HCT) includes
revaccination to restore immunity to vaccine-preventable diseases (VPDs). There is …

Introduction: Allogeneic hematopoietic stem cell transplantation (HSCT) is a major curative
treatment option for malignant and non-malignant hematological diseases, but is associated …

Allogeneic hematopoietic stem cell transplantation (alloHSCT) results in a loss of humoral
immunity and subsequent risk for severe infections. Thus, re-vaccination is required but may …